Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glutathione biosynthesis enhancement via precursor function refers to increasing intracellular glutathione (GSH) levels by supplying or modulating the availability of its amino acid precursors—primarily cysteine—and regulating the activity or expression of key biosynthetic enzymes like Glutamate–Cysteine Ligase (GCL) and Glutathione Synthetase (GS). It is a therapeutic strategy to combat oxidative stress and improve cellular function in various diseases.
Providing rate-limiting precursors (primarily cysteine) to enhance glutathione synthesis; Activating Nrf2 pathway to upregulate glutathione synthesis enzymes
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glutathione Biosynthesis Enhancement via Precursor Function (None).